{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:04:29Z","timestamp":1787015069754,"version":"build-2736575974"},"reference-count":34,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1527,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1111\/j.1600-0536.2011.01946.x","type":"journal-article","created":{"date-parts":[[2011,6,30]],"date-time":"2011-06-30T07:48:36Z","timestamp":1309420116000},"page":"195-201","source":"Crossref","is-referenced-by-count":111,"title":["Patch testing in fixed drug eruptions-a 20-year review"],"prefix":"10.1111","volume":"65","author":[{"given":"Pedro","family":"Andrade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Brinca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarida","family":"Gon\u00e7alo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,6,27]]},"reference":[{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1684\/ejd.2010.0980","article-title":"A three-year-analysis of fixed drug eruptions in hospital settings in France.","volume":"20","author":"Brahimi","year":"2010","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/00128071-200001050-00003","article-title":"Fixed drug eruptions. Incidence, recognition, and avoidance.","volume":"1","author":"Lee","year":"2000","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1365-4632.2006.02853.x","article-title":"Fixed drug eruption (FDE): changing scenario of incriminating drugs.","volume":"45","author":"Sehgal","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1610-0387.2007.06491.x","article-title":"Fixed drug eruption: state of the art.","volume":"6","author":"Ozkaya","year":"2008","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.tox.2004.12.024","article-title":"Drug patch testing in systemic cutaneous drug allergy.","volume":"209","author":"Barbaud","year":"2005","journal-title":"Toxicology"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1365-2133.2005.06429.x","article-title":"The usefulness of skin tests to prove drug hypersensitivity.","volume":"152","author":"Lammintausta","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000058337","article-title":"Topical provocation in 31 cases of fixed drug eruption.","volume":"1","author":"Gon\u00e7alo","year":"2002","journal-title":"Exogenous Dermatol"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1600-0536.1998.tb05739.x","article-title":"Topical provocation in 31 cases of fixed drug eruption: change of causative drugs in 10 years.","volume":"38","author":"Lee","year":"1998","journal-title":"Contact Dermatitis"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1034\/j.1600-0536.2001.450601.x","article-title":"Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions.","volume":"45","author":"Barbaud","year":"2001","journal-title":"Contact Dermatitis"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB10|cit10","first-page":"1295","article-title":"Cutaneous drug eruption with two antihistaminic drugs of a same chemical family: cetirizine and hydroxyzine.","volume":"129","author":"Assou\u00e8re","year":"2002","journal-title":"Ann Dermatol Venereol"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1365-4632.2007.03131.x","article-title":"Fixed drug eruption to cetirizine with positive lesional patch tests to the three piperazine derivatives.","volume":"46","author":"Cravo","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1600-0536.1993.tb03329.x","article-title":"Fixed drug eruption to piroxicam","volume":"28","author":"Gastaminza","year":"1993","journal-title":"Contact Dermatitis"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1398-9995.1995.tb01216.x","article-title":"Cross-sensitivity among oxicams in piroxicam-caused fixed drug eruption: two case reports.","volume":"50","author":"Ordoqui","year":"1995","journal-title":"Allergy"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1300.","DOI":"10.1016\/S0190-9622(89)80308-1","article-title":"Nonpigmenting fixed drug eruption to piroxicam.","volume":"21","author":"Valsecchi","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/09546639909056032","article-title":"Fixed drug eruption to piroxicam. Positive patch tests with cross-sensitivity to tenoxicam.","volume":"10","author":"Oliveira","year":"1999","journal-title":"J Dermatol Treat"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa022963","article-title":"Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics.","volume":"349","author":"Strom","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000312632","article-title":"Cross-reactivity in drug hypersensitivity reactions to sulfasalazine and sulfamethoxazole.","volume":"153","author":"Zawodniak","year":"2010","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11882-009-0011-8","article-title":"Fixed drug eruption: a prototypic disorder mediated by effector memory T cells.","volume":"9","author":"Mizukawa","year":"2009","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/15569527.2010.484824","article-title":"Nonpigmented fixed drug eruption induced by esomeprazole.","volume":"29","author":"Morais","year":"2010","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB20|cit20","first-page":"399","article-title":"Nonpigmented fixed drug eruption caused by paracetamol.","volume":"9","author":"Galindo","year":"1999","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0190-9622(85)70110-7","article-title":"Cutaneous reactions to nonsteroidal anti-inflammatory drugs.","volume":"12","author":"Bigby","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1600-0536.1994.tb01900.x","article-title":"Topical provocation of fixed drug eruption. A study of 30 patients.","volume":"31","author":"Alanko","year":"1994","journal-title":"Contact Dermatitis"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB23|cit23","first-page":"307.","article-title":"Positive lesional patch tests in fixed drug eruptions from nimesulide.","volume":"43","author":"Robalo-Cordeiro","year":"2000","journal-title":"Contact Dermatitis"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1600-0536.2010.01847.x","article-title":"Fixed drug eruption caused by etoricoxib - 2 cases confirmed by patch testing.","volume":"64","author":"Andrade","year":"2011","journal-title":"Contact Dermatitis"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2230.2004.01537.x","article-title":"Topical provocation in fixed drug eruption due to metamizol and naproxen.","volume":"29","author":"Ozkaya-Bayazit","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1600-0536.1999.tb06127.x","article-title":"Topical provocation in 27 cases of cotrimoxazole-induced fixed drug eruption","volume":"41","author":"Ozkaya-Bayazit","year":"1999","journal-title":"Contact Dermatitis"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/ACI.0b013e32833aa54d","article-title":"Patch testing in drug allergy.","volume":"10","author":"Friedmann","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000069759","article-title":"Skin penetration of topical formulations of ibuprofen 5%: an in vitro comparative study.","volume":"16","author":"Hadgraft","year":"2003","journal-title":"Skin Pharmacol Appl Skin Physiol"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"155.","DOI":"10.1111\/j.1600-0536.1993.tb03515.x","article-title":"Topical provocation of fixed drug eruption due to sulphamethoxazole.","volume":"29","author":"Oleaga","year":"1993","journal-title":"Contact Dermatitis"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-0536.1998.tb05844.x","article-title":"Trimethoprim-induced fixed drug eruption: positive topical provocation on previously involved and uninvolved skin.","volume":"39","author":"Ozkaya-Bayazit","year":"1998","journal-title":"Contact Dermatitis"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/clin.1994.1022","article-title":"Cell-mediated immunity in allopurinol-induced hypersensitivity.","volume":"70","author":"Braden","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/art.1780310318","article-title":"Some adverse reactions to allopurinol may be mediated by lymphocyte reactivity to oxypurinol.","volume":"31","author":"Emmerson","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1365-2230.1998.00311.x","article-title":"Allopurinol hypersensitivity syndrome: hypersensitivity to oxypurinol but not allopurinol","volume":"23","author":"Hamanaka","year":"1998","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1600-0536.2011.01946.x-BIB34|cit34","first-page":"247","article-title":"Testes epicut\u00e2neos ao alopurinol e oxipurinol em doentes com toxidermias ao alopurinol.","volume":"62","author":"Vieira","year":"2004","journal-title":"Trab Soc Port Dermatol Venereol"}],"container-title":["Contact Dermatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0536.2011.01946.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0536.2011.01946.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T03:49:11Z","timestamp":1625629751000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0536.2011.01946.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,27]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0536.2011.01946.x","relation":{},"ISSN":["0105-1873"],"issn-type":[{"value":"0105-1873","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6,27]]}}}